Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Erratum

Erratum ErratumIn the paper by Kerwin, D, Abdelnour, C, Caramelli, P, et al. (“Alzheimer's disease diagnosis and management: Perspectives from around the world.” Alzheimer's Dement. 2022; 14:e12334. https://doi.org/10.1002/dad2.12334), five errors occurred in the preparation of the paper for publication, requiring the following correction.In the initial publication of this article, Table 2 should not include an asterisk after “Nigeria” in the country column.Second, reference number 8 should be updated to: France Alzheimer. Personnes malades jeunes: Les oubliées d'Alzheimer. https://www.francealzheimer.org/personnes‐malades‐jeunes‐lesoubliees‐dalzheimer/. Accessed 20 May 2021.Third, reference number 18 should be updated to: Boada M, Rodrigo A, Jessen F, et al. Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project. Alzheimers Dement. 2022;18:1119‐1127.Fourth, reference number 19 should be updated to: Balasa M, Ripoll GP, Guix JLM, et al. Guies clíniques dt'us debiomarcadors de malaltia d'Alzheimer en el líquid cefalorraquidien l'avaluació de pacients amb deteriorament cognitiu. https://www.academia.cat/files/204‐3749‐FITXER/GUIESCLNIQUESUSBIOMARCADORSJULIOL2015DEFINITIVA.pdf. Accessed 22 September 2021.Fifth, reference number 26 should be updated to: Andreasen N, Blennow K, Zetterberg H. Neuroinflammation screening in immunotherapy trials against Alzheimer's disease. Int J Alzheimers Dis. 2010;638379.The authors regret these errors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Wiley

Erratum

Download PDF
1 page

Loading next page...
 
/lp/wiley/erratum-278oednH9Q

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
© 2023 the Alzheimer's Association.
eISSN
2352-8729
DOI
10.1002/dad2.12397
Publisher site
See Article on Publisher Site

Abstract

ErratumIn the paper by Kerwin, D, Abdelnour, C, Caramelli, P, et al. (“Alzheimer's disease diagnosis and management: Perspectives from around the world.” Alzheimer's Dement. 2022; 14:e12334. https://doi.org/10.1002/dad2.12334), five errors occurred in the preparation of the paper for publication, requiring the following correction.In the initial publication of this article, Table 2 should not include an asterisk after “Nigeria” in the country column.Second, reference number 8 should be updated to: France Alzheimer. Personnes malades jeunes: Les oubliées d'Alzheimer. https://www.francealzheimer.org/personnes‐malades‐jeunes‐lesoubliees‐dalzheimer/. Accessed 20 May 2021.Third, reference number 18 should be updated to: Boada M, Rodrigo A, Jessen F, et al. Complementary pre‐screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project. Alzheimers Dement. 2022;18:1119‐1127.Fourth, reference number 19 should be updated to: Balasa M, Ripoll GP, Guix JLM, et al. Guies clíniques dt'us debiomarcadors de malaltia d'Alzheimer en el líquid cefalorraquidien l'avaluació de pacients amb deteriorament cognitiu. https://www.academia.cat/files/204‐3749‐FITXER/GUIESCLNIQUESUSBIOMARCADORSJULIOL2015DEFINITIVA.pdf. Accessed 22 September 2021.Fifth, reference number 26 should be updated to: Andreasen N, Blennow K, Zetterberg H. Neuroinflammation screening in immunotherapy trials against Alzheimer's disease. Int J Alzheimers Dis. 2010;638379.The authors regret these errors.

Journal

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring – Wiley

Published: Jan 1, 2023

There are no references for this article.